AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31547970 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary angiography before surgery
Number of subjects: 10
Study 29961975 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp 30 plus metformin
Number of subjects: 257
Study 29961975 — intervention group
Group type: COMPARATOR
Intervention: BIAsp 30
Number of subjects: 257
Study 26978655 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 25306749 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 2000 mg daily for 3 months
Number of subjects: 46
Study 25306749 — intervention group
Group type: COMPARATOR
Intervention: No medication (comparison group)
Number of subjects: 46
Study 22791230 — intervention group
Group type: COMPARATOR
Intervention: Viewing fingers (visual condition)
Number of subjects: 0
Study 22791230 — intervention group
Group type: COMPARATOR
Intervention: Fingers far apart or touching (visual condition)
Number of subjects: 0
Study 20139221 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV6/11/16/18 vaccine
Number of subjects: 17622
Study 17371782 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin
Number of subjects: 0
Study 17371782 — intervention group
Group type: COMPARATOR
Intervention: Generic simvastatin 20-40 mg
Number of subjects: 0
Study 15635619 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 24
Study 12139646 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger-pressing group
Number of subjects: 150
Study 12139646 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-band group
Number of subjects: 150
Study 12139646 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 10208247 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (barometric pressure, P(B) = 594 hPa, altitude 4,400 m)
Number of subjects: 6
Study 10208247 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (P(B) = 992 hPa)
Number of subjects: 6
Study 10208247 — intervention group
Group type: EXPERIMENTAL
Intervention: Both hypoxia and normoxia
Number of subjects: 6
Study 10208247 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia and Normoxia
Number of subjects: 6
Study 10208247 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 6
Study 7596725 — intervention group
Group type: EXPERIMENTAL
Intervention: Body rocking
Number of subjects: 18
Study 7596725 — intervention group
Group type: COMPARATOR
Intervention: Nonrocking mattress
Number of subjects: 18
Study 1605593 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical mupirocin
Number of subjects: 102
Study 1605593 — intervention group
Group type: COMPARATOR
Intervention: Oral erythromycin
Number of subjects: 102
Study 6318545 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy hulls (26 g daily)
Number of subjects: 18
Study 6318545 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn bran (52 g daily)
Number of subjects: 18
Study 6318545 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple powder (52 g daily)
Number of subjects: 18
Study 6318545 — intervention group
Group type: COMPARATOR
Intervention: Low fiber white bread
Number of subjects: 18
Study 29543122 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodex Stability System at 12:00 hours
Number of subjects: 33
Study 29543122 — intervention group
Group type: COMPARATOR
Intervention: Biodex Stability System at 07:00 hours
Number of subjects: 33
Study 29543122 — intervention group
Group type: COMPARATOR
Intervention: Star Excursion Balance Test
Number of subjects: 33
Study 29543122 — intervention group
Group type: COMPARATOR
Intervention: Isokinetic inversion: eversion ratio
Number of subjects: 33
Study 29543122 — intervention group
Group type: COMPARATOR
Intervention: Joint position sense
Number of subjects: 33
Study 29543122 — intervention group
Group type: COMPARATOR
Intervention: Drop-landing inversion cutting maneuver
Number of subjects: 33
Study 30015795 — intervention group
Group type: EXPERIMENTAL
Intervention: EtCO2 monitoring
Number of subjects: 200
Study 30015795 — intervention group
Group type: COMPARATOR
Intervention: Standard monitoring
Number of subjects: 200
Study 27027093 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-piece zirconia abutment with pressed layer of lithium disilicate and all-ceramic cemented restoration
Number of subjects: 65
Study 27027093 — intervention group
Group type: EXPERIMENTAL
Intervention: One-piece zirconia abutment with porcelain fired and pressed straight to the abutment
Number of subjects: 65
Study 27027093 — intervention group
Group type: COMPARATOR
Intervention: Both one-piece and two-piece groups
Number of subjects: 65
Study 25022824 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication education group (group I)
Number of subjects: 109
Study 25022824 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication education with behavioral intervention group (group II)
Number of subjects: 109
Study 22340371 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure bandage and tape
Number of subjects: 180
Study 22340371 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure bandage and brace
Number of subjects: 180
Study 22340371 — intervention group
Group type: COMPARATOR
Intervention: No external support
Number of subjects: 180
Study 20375696 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (pressure therapy + silicone gel sheeting)
Number of subjects: 104
Study 20375696 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure therapy (PG)
Number of subjects: 104
Study 20375696 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel sheeting (SGS)
Number of subjects: 104
Study 20375696 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 17379120 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative nausea and vomiting (PONV) assessment at various time intervals (0‐2, 2‐6, and 6‐24 hours) using a 4‐point scale
Number of subjects: 49
Study 17379120 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanometric measurements (gradient, compliance, pressure)
Number of subjects: 49
Study 17379120 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume measurements of both ears
Number of subjects: 49
Study 17379120 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis between middle ear pressure changes and PONV
Number of subjects: 49
Study 15670021 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdischarge Dalteparin for 1 week
Number of subjects: 209
Study 15670021 — intervention group
Group type: COMPARATOR
Intervention: No further prophylaxis
Number of subjects: 209
Study 12102384 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus nurse-delivered intervention based on cognitive-behavioural principles
Number of subjects: 80
Study 12102384 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 80
Study 10336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced elated mood with forbidden foods in imagined eating situations
Number of subjects: 212
Study 10336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced depressed mood with forbidden foods in imagined eating situations
Number of subjects: 212
Study 10336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced elated mood with non-forbidden foods in imagined eating situations
Number of subjects: 212
Study 10336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced depressed mood with non-forbidden foods in imagined eating situations
Number of subjects: 212
Study 10336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating forbidden foods in real eating situations
Number of subjects: 212
Study 10336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating non-forbidden foods in real eating situations
Number of subjects: 212
Study 10336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagining eating forbidden foods
Number of subjects: 212
Study 10336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagining eating non-forbidden foods
Number of subjects: 212
Study 8535536 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-receptor blockers and/or diuretics
Number of subjects: 0
Study 8535536 — intervention group
Group type: COMPARATOR
Intervention: Calcium antagonists, alpha 1 blockers, and ACE inhibitors
Number of subjects: 0
Study 2227079 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg rectally, administered one to three times daily for a mean period of 2.5 days)
Number of subjects: 50
Study 2227079 — intervention group
Group type: COMPARATOR
Intervention: Dipyrone (controlled group, administered one to three times daily for a mean period of 2.5 days)
Number of subjects: 50
Study 324577 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for mild hypertension
Number of subjects: 1800
Study 31989472 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone
Number of subjects: 108
Study 31989472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 31386646 — intervention group
Group type: EXPERIMENTAL
Intervention: General population screening for vascular disease
Number of subjects: 0
Study 27811526 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB)
Number of subjects: 93
Study 27811526 — intervention group
Group type: COMPARATOR
Intervention: Femoral Nerve Block (FNB)
Number of subjects: 93
Study 24983295 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified constraint‐induced movement therapy (CIMT)
Number of subjects: 12
Study 24983295 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand‐arm bimanual intensive therapy (HABIT)
Number of subjects: 12
Study 24654314 — intervention group
Group type: EXPERIMENTAL
Intervention: MP29-02 (1 spray/nostril bid)
Number of subjects: 612
Study 24654314 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) nasal spray (2 sprays/nostril qd)
Number of subjects: 612
Study 21271793 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 100
Study 21271793 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg plus Ezetimibe 10 mg
Number of subjects: 100
Study 19432566 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg) and Vitamin E (400 iu) daily until delivery
Number of subjects: 1365
Study 16415406 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 28
Study 16415406 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 28
Study 15257794 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mg primaquine
Number of subjects: 89
Study 15257794 — intervention group
Group type: COMPARATOR
Intervention: No primaquine (Control)
Number of subjects: 89
Study 11747872 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg LNG taken 12 h apart on day 10 of the cycle (Group A)
Number of subjects: 45
Study 11747872 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg LNG at the time of serum LH surge (Group B)
Number of subjects: 45
Study 11747872 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg LNG 48 h after positive detection of urinary LH (Group C)
Number of subjects: 45
Study 11747872 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg LNG during late follicular phase (Group D)
Number of subjects: 45
Study 9413765 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol-mannitol irrigation fluid (2.7% sorbitol and 0.54% mannitol)
Number of subjects: 92
Study 9413765 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 92
Study 8400610 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium gluconolactate (CG)
Number of subjects: 10
Study 8400610 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium gluconolactate (CG')
Number of subjects: 10
Study 8400610 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricalcium phosphate (TCP)
Number of subjects: 10
Study 8400610 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate (CC)
Number of subjects: 10
Study 3546949 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX) plus cis‐diamminodichloroplatinum (DDP)
Number of subjects: 6
Study 3546949 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX) plus BCG treatment
Number of subjects: 6
Study 3546949 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CTX)
Number of subjects: 6
Study 3546949 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with pretreatment residual disease less than 2 cm
Number of subjects: 6
Study 3546949 — intervention group
Group type: COMPARATOR
Intervention: Univariate analysis of pretreatment prognostic factors
Number of subjects: 6
Study 29771563 — intervention group
Group type: EXPERIMENTAL
Intervention: Sadness induction
Number of subjects: 60
Study 29771563 — intervention group
Group type: COMPARATOR
Intervention: No emotional induction (control)
Number of subjects: 60
Study 25766509 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (6 weeks, 3 sessions/week)
Number of subjects: 27
Study 23711798 — intervention group
Group type: EXPERIMENTAL
Intervention: Imageless navigation
Number of subjects: 40
Study 23711798 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 40
Study 23616154 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 0
Study 23616154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20012877 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years parent training program (PT)
Number of subjects: 0
Study 20012877 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined parent training and child treatment (PT + CT)
Number of subjects: 0
Study 20012877 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 18753925 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 2752
Study 18753925 — intervention group
Group type: COMPARATOR
Intervention: Didanosine
Number of subjects: 2752
Study 18753925 — intervention group
Group type: COMPARATOR
Intervention: Other NRTIs
Number of subjects: 2752
Study 15961987 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenadrine RFA (25 mg ephedra alkaloids and 200 mg caffeine)
Number of subjects: 16
Study 15961987 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedra-guarana
Number of subjects: 16
Study 15961987 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenadrine RFA
Number of subjects: 16
Study 15961987 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 16
Study 12869911 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aqueous nasal spray (TAA AQ) 220 microg daily
Number of subjects: 295
Study 12869911 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 200 microg daily
Number of subjects: 295
Study 12869911 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TAA AQ and FP
Number of subjects: 295
Study 10553743 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure (N = 14)
Number of subjects: 45
Study 10553743 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure plus anxiety management (N = 15)
Number of subjects: 45
Study 10553743 — intervention group
Group type: COMPARATOR
Intervention: Supportive counseling (N = 16)
Number of subjects: 45
Study 10553743 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure (N = 13)
Number of subjects: 45
Study 10553743 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure plus anxiety management (N = 13)
Number of subjects: 45
Study 10553743 — intervention group
Group type: COMPARATOR
Intervention: Supportive counseling (N = 15)
Number of subjects: 45
Study 8551406 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg per day oral prednisone for 6 to 12 weeks
Number of subjects: 60
Study 8551406 — intervention group
Group type: COMPARATOR
Intervention: 3 mg/kg per day oral prednisone for 6 to 12 weeks
Number of subjects: 60
Study 1702493 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (cisplatin-based combination chemotherapy)
Number of subjects: 86
Study 1702493 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjuvant chemotherapy)
Number of subjects: 86
Study 6682631 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate
Number of subjects: 246
Study 6682631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study 6682631 — intervention group
Group type: EXPERIMENTAL
Intervention: Military dependent population
Number of subjects: 246
Study 30887627 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT)
Number of subjects: 50
Study 27839810 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mm sampling interval
Number of subjects: 38
Study 27839810 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6-mm sampling interval
Number of subjects: 38
Study 26644115 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory training (composite of Hopkins Verbal Learning Test, Rey Auditory Verbal Learning Test, Rivermead Behavioral Memory Test)
Number of subjects: 2800
Study 26644115 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning training (composite of letter series, letter sets, word series)
Number of subjects: 2800
Study 26644115 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed of processing training (measured using useful field of view and digit symbol substitution test)
Number of subjects: 2800
Study 26644115 — intervention group
Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 2800
Study 23830530 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous fentanyl
Number of subjects: 20
Study 23830530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 22217192 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/Losartan 50 mg
Number of subjects: 320
Study 22217192 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/Losartan 50 mg
Number of subjects: 320
Study 22217192 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/Losartan 100 mg
Number of subjects: 320
Study 22217192 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/Losartan 100 mg
Number of subjects: 320
Study 22217192 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine camsylate/Losartan 5 mg/50 mg
Number of subjects: 320
Study 22217192 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine camsylate/Losartan 5 mg/100 mg
Number of subjects: 320
Study 22217192 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine camsylate/Losartan 10 mg/50 mg
Number of subjects: 320
Study 22217192 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine camsylate/Losartan 10 mg/100 mg
Number of subjects: 320
Study 19533522 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (HF) TENS (80 Hz)
Number of subjects: 24
Study 19533522 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (LF) TENS (burst of 2 Hz)
Number of subjects: 24
Study 19533522 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 24
Study 18166819 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 131
Study 18166819 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 131
Study 18166819 — intervention group
Group type: COMPARATOR
Intervention: Radioiodine therapy
Number of subjects: 131
Study 16259286 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of dietary calcium plus physical activity 30 minutes three times per week
Number of subjects: 82
Study 16259286 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of calcium citrate plus 500 mg of dietary calcium and physical activity three times per week
Number of subjects: 82
Study 16259286 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study 12181213 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise testing
Number of subjects: 67
Study 12181213 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 67
Study 10190267 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 35
Study 10190267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 7479227 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) treatment using cuprophan dialyzers and acetate containing solution (35 mEq/l), 4 hours, 3 times weekly.
Number of subjects: 20
Study 7479227 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) treatment (group I with hypotensive episodes).
Number of subjects: 20
Study 7479227 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) treatment (group II without hypotensive episodes).
Number of subjects: 20
Study 7479227 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects).
Number of subjects: 20
Study 2205694 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive pressure breathing (19 ± 1 mm Hg for 30 minutes) after water loading
Number of subjects: 7
Study 2205694 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous negative pressure breathing (11 ± 1 mm Hg for 30 minutes) after maintenance water ingestion
Number of subjects: 7
Study 2205694 — intervention group
Group type: COMPARATOR
Intervention: Control day without pressure breathing
Number of subjects: 7
Study 6997154 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprazinone dihydrochloride (Eftapan)
Number of subjects: 0
Study 6997154 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 30905546 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) applied for 5 days
Number of subjects: 36
Study 30905546 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 36
Study 28056906 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural change interventions
Number of subjects: 0
Study 28056906 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study 25719252 — intervention group
Group type: EXPERIMENTAL
Intervention: CEM‐530
Number of subjects: 69
Study 25719252 — intervention group
Group type: EXPERIMENTAL
Intervention: Perseus
Number of subjects: 69
Study 25719252 — intervention group
Group type: EXPERIMENTAL
Intervention: CellChek XL
Number of subjects: 69
Study 25719252 — intervention group
Group type: EXPERIMENTAL
Intervention: EM‐3000
Number of subjects: 69